Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study
The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained athletes, levels of ferritin between 15 and 30 microg/L are frequently observed. Within this ferritin range, the usefulness of iron supplementati...
Saved in:
Published in: | Journal of biological regulators and homeostatic agents Vol. 25; no. 3; p. 427 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Italy
01-07-2011
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained athletes, levels of ferritin between 15 and 30 microg/L are frequently observed. Within this ferritin range, the usefulness of iron supplementation is still controversial. The aim of the present study is to evaluate the clinical usefulness of hepcidin assessment in the analysis of the iron status of young non-anemic athletes. Fifty young athletes were enrolled. The subjects were divided into 4 groups according to their ferritin levels. No statistically significant difference was found regarding hepcidin levels between athletes with ferritin lower than 15 microg/L and those in the 15-30 microg/L range. Similarly, no difference was found between athletes with ferritin higher than 50 microg/L and those in the 30-50 microg/L range. On the contrary, statistically significant differences were found between athletes with ferritin levels ranging from 15 to 30 microg/L and those in the 30-50 microg/L range. The present study suggests that serum ferritin levels below 30 microg/L indicate an asymptomatic iron deficiency status inhibiting hepcidin expression and that 30 microg/L should be considered the ferritin cut-off when considering an iron supplementation in young athletes. |
---|---|
AbstractList | The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained athletes, levels of ferritin between 15 and 30 microg/L are frequently observed. Within this ferritin range, the usefulness of iron supplementation is still controversial. The aim of the present study is to evaluate the clinical usefulness of hepcidin assessment in the analysis of the iron status of young non-anemic athletes. Fifty young athletes were enrolled. The subjects were divided into 4 groups according to their ferritin levels. No statistically significant difference was found regarding hepcidin levels between athletes with ferritin lower than 15 microg/L and those in the 15-30 microg/L range. Similarly, no difference was found between athletes with ferritin higher than 50 microg/L and those in the 30-50 microg/L range. On the contrary, statistically significant differences were found between athletes with ferritin levels ranging from 15 to 30 microg/L and those in the 30-50 microg/L range. The present study suggests that serum ferritin levels below 30 microg/L indicate an asymptomatic iron deficiency status inhibiting hepcidin expression and that 30 microg/L should be considered the ferritin cut-off when considering an iron supplementation in young athletes. |
Author | Borrione, P Chierto, E Quaranta, F Pigozzi, F Spaccamiglio, A Termine, A Di Gianfrancesco, A Rizzo, M Campostrini, N |
Author_xml | – sequence: 1 givenname: P surname: Borrione fullname: Borrione, P organization: Department of Health Sciences, University of Rome Foro Italico, Rome, Italy – sequence: 2 givenname: A surname: Spaccamiglio fullname: Spaccamiglio, A – sequence: 3 givenname: M surname: Rizzo fullname: Rizzo, M – sequence: 4 givenname: A surname: Termine fullname: Termine, A – sequence: 5 givenname: E surname: Chierto fullname: Chierto, E – sequence: 6 givenname: N surname: Campostrini fullname: Campostrini, N – sequence: 7 givenname: F surname: Quaranta fullname: Quaranta, F – sequence: 8 givenname: A surname: Di Gianfrancesco fullname: Di Gianfrancesco, A – sequence: 9 givenname: F surname: Pigozzi fullname: Pigozzi, F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22023767$$D View this record in MEDLINE/PubMed |
BookMark | eNo1T8tKAzEUzaJiH_oLkh8YSG-imbiT4gsK3VhwV5LJjY3MZEIei_69AZWzOBzOA86aLMIccEFWjCveKSk-l2Sd8zdjggspr8kSgAGXD3JFwjH5oNOFnjEO3vpAvcVQvPOYqaYZU52ow5R8ad5QSzc7R92cqE9zoLnGOOLUGrr4plvmMtfwRXU5j1gwP7aR6Me50FyqvdyQK6fHjLd_vCHHl-eP3Vu3P7y-7572XYQtK53ijvcgGLDegNFmQKNtg7BGS8eUGSzw3rjeKVQGrDDADArmBtgq5e5hQ-5-d2M1E9pTTH5qL0__x-EHrMRZPQ |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
ExternalDocumentID | 22023767 |
Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 53G 5GY ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK ECM EIF F5P FRP NPM NQS OK1 P2P SV3 TR2 |
ID | FETCH-LOGICAL-p210t-93f38240208b2babcebadada4dba7f09bcd238bf8f9e9b2d4b20be40fc2199f52 |
ISSN | 0393-974X |
IngestDate | Wed Mar 27 02:17:51 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p210t-93f38240208b2babcebadada4dba7f09bcd238bf8f9e9b2d4b20be40fc2199f52 |
PMID | 22023767 |
ParticipantIDs | pubmed_primary_22023767 |
PublicationCentury | 2000 |
PublicationDate | 2011 Jul-Sep |
PublicationDateYYYYMMDD | 2011-07-01 |
PublicationDate_xml | – month: 07 year: 2011 text: 2011 Jul-Sep |
PublicationDecade | 2010 |
PublicationPlace | Italy |
PublicationPlace_xml | – name: Italy |
PublicationTitle | Journal of biological regulators and homeostatic agents |
PublicationTitleAlternate | J Biol Regul Homeost Agents |
PublicationYear | 2011 |
SSID | ssj0043477 |
Score | 1.9676841 |
Snippet | The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 427 |
SubjectTerms | Adolescent Antimicrobial Cationic Peptides - urine Athletes Dietary Supplements Female Ferritins - blood Hepcidins Humans Iron - administration & dosage Male Pilot Projects |
Title | Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22023767 |
Volume | 25 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La-MwEBZJl0IvS3f73gc67M0YHFuO7N6Wbkovu4dtCr0VjS21hiY2jXNof_3OSFbjZCm0h2IwjmSM0HySZiYz3zD2I9NoNJgcQlkqCIWCKFQyAlzuKZ6-ShUypdzhi0v55zr7NRGTwcAXSV21vauksQ1lTZmzb5D280exAZ9R5nhHqeP9VXK_enAZtne6KSo8mIKqdAFBehGoAIewnAWG6BhbikBftmFtjI01pHy3YEFFPl1AuY-CfKT9ILBBF60LoFNBU93XbY-a9n_t1pE7WQQ8uHL3VNWHvPR39UzXlMdETLG3nkrKhSzisOr5etrZJRr1hZpVt_dVveZ7_Vs9PdVr_typDezpeWjLlXtWem9Gl8WVJyHaONf9HdqlRndITHrbrXC8Aj2xNjMr15iqwsvxK3o32LZ915ANUXci9frstz_ZRSJsJc_nMRKTdPf-hlVitZPpLvvYTTz_6fDwiQ30_DPbdoVGH_fYvEMF96jgK1RwxS0quEcF71DBERWcUME3UMHxHYsK7lFxih-xmOAWE_vs6nwyPbsIu0obYYMmfxvmiUky-p8tyiAGBYUGVeIlSlDSRDkUJap2YDKT6xziUkAcAa5yU-CBl5s0PmBbc8THEeNQSEkcQGk6BjGKpUrxt05Go2KcgjDRMTt0E3XTODqVGz-FJy_2fGE7K6x8ZR8MrlX9jQ0X5fK7ldA_E9hpRw |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+hepcidin+identifies+a+serum+ferritin+cut-off+for+iron+supplementation+in+young+athletes%3A+a+pilot+study&rft.jtitle=Journal+of+biological+regulators+and+homeostatic+agents&rft.au=Borrione%2C+P&rft.au=Spaccamiglio%2C+A&rft.au=Rizzo%2C+M&rft.au=Termine%2C+A&rft.date=2011-07-01&rft.issn=0393-974X&rft.volume=25&rft.issue=3&rft.spage=427&rft_id=info%3Apmid%2F22023767&rft_id=info%3Apmid%2F22023767&rft.externalDocID=22023767 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0393-974X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0393-974X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0393-974X&client=summon |